[1]
Aisha Alyassi et al. 2024. META-ANALYSIS OF CARDIOPROTECTIVE EFFECTS OF COMBINED SGLT2 INHIBITORS AND GLP-1 RECEPTOR AGONISTS VS. MONOTHERAPY IN PATIENTS WITH TYPE 2 DIABETES AND HEART FAILURE: IMPACT ON MORTALITY AND HOSPITALIZATION OUTCOMES. Insights – Journal of Health and Rehabilitation. 2, 3 (Nov. 2024), 176–186. DOI:https://doi.org/10.71000/ijhr139.